[Vaccination against feline retrovirus infections].
Feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV), both of veterinary importance, their antigenic and genetic variability as well as their pathogenicity are described. Disease following FeLV infection is interpreted as a consequence of genetic recombination, as a result of viral evolution in vivo. The principles and efficacy of vaccines are discussed.
Horzinek
M C
MC
Institute of Veterinary Research, Veterinärmedizinischen Fakultät, Universität Utrecht, Niederlande.
D000818:Animals; D002415:Cats; D016181:Feline Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D016089:Immunodeficiency Virus, Feline / Q000276:immunology* / Q000472:pathogenicity; D005256:Leukemia Virus, Feline / Q000276:immunology* / Q000472:pathogenicity; D012192:Retroviridae Infections / Q000517:prevention & control / Q000662:veterinary*; D015682:Retroviridae Proteins, Oncogenic; D014765:Viral Vaccines
D015682:Retroviridae Proteins, Oncogenic; D014765:Viral Vaccines; C045569:feline leukemia virus vaccine
Impfung gegen feline Retrovirusinfektionen.